echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > BMJ Sub-Journal: Toxoplasma gondii has become a new hope for tumor treatment

    BMJ Sub-Journal: Toxoplasma gondii has become a new hope for tumor treatment

    • Last Update: 2021-11-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    .


     

    In this study, the researchers first modified the mutant strain of Toxoplasma gondii to have a limited growth ability, causing diseases in cultured cells or mice, but at the same time being able to manipulate the host immune system


     

    In a mouse model, direct injection of this mutant parasite can induce an inflammatory response in the injected tumor or even in the distant tumor of the mouse


     

    After modified Toxoplasma gondii and anti-PD-L1 treatment, the survival time of melanoma, lung cancer and colon adenocarcinoma model mice was significantly prolonged, and tumor growth was reduced


     

     

    Intratumoral administration of Toxoplasma can inhibit the growth of non-injected distant tumors

     

    The researchers said that the study confirmed the effectiveness of intratumoral injection of mutant Toxoplasma strains to improve anti-tumor immunity and checkpoint suppression therapy


     

    In summary, intratumoral injection of mutant Toxoplasma gondii can induce systemic effects, improve the immune response of mice, sensitize immune "cold" tumors, and make mice susceptible to immune checkpoint blocking therapy


     Article link: http://dx.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.